Source Post
9/8/25 +55% atyr watch day 4 PART 2
Sep 8, 2025
The creator discusses the biotech company Avivax, noting its current call and potential. He also reflects on Celgene's history, particularly its hit product Revlimid and its limitations. The creator mentions a potential trade on 'Octo' due to its perceived market inefficiency, drawing a parallel to a past successful trade with Espa.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.